You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
There is a dearth of standardized criteria for biomarker testing quality and access across the region, according to the report.
The company was cleared to begin a Phase I/II trial of its lead candidate, a therapeutic vaccine that can potentially treat and prevent recurrence of KRAS-mutated cancers.
Lynparza is already approved to treat metastatic prostate cancer with BRCA1/2 mutations in Europe and the US.
C2i said that the acquisition would help it commercialize its MRDetect cancer monitoring platform as a reimbursable laboratory-developed test.
The trial will be the first AML study to use next-generation sequencing to determine MRD-negative complete response rates as a primary endpoint.
Medicare patients on FDA-approved cancer treatments in the real world do not live as long as patients in pivotal clinical trials, according to an MSK analysis.